```html

Adenocarcinoma of the Colon

Overview

Adenocarcinoma of the colon is a malignant tumor that arises from the glandular epithelial cells lining the inner surface of the large intestine. It is the most common type of colorectal cancer, accounting for roughly 95% of all colorectal malignancies.<sup>CDC</sup>

The disease typically affects adults over the age of 50, but incidence is rising among younger adults, with a 51% increase in diagnoses for people aged 20‑49 in the United States between 1992 and 2019.<sup>American Cancer Society</sup> Men have a slightly higher risk than women, and African‑American individuals bear a disproportionately higher burden of both incidence and mortality.<sup>CDC</sup>

Symptoms

Early-stage colon adenocarcinoma often produces few or no symptoms. When symptoms appear, they may be subtle and can mimic benign gastrointestinal disorders. A complete list includes:

• Changes in bowel habits – persistent diarrhea, constipation, or a feeling that the bowel does not empty completely.
• Rectal bleeding or blood in stool – may appear bright red or cause dark, tarry stools (melena).
• Abdominal pain or cramping – often described as a vague, persistent discomfort.
• Unexplained weight loss – loss of appetite combined with metabolic changes.
• Fatigue – commonly due to anemia from chronic blood loss.
• Feeling of fullness – especially after eating small amounts.
• Nausea or vomiting – can occur if the tumor obstructs the colon.
• Change in stool caliber – narrower or pencil‑thin stools.
• Generalized weakness or malaise – may accompany advanced disease.

Causes and Risk Factors

Colon adenocarcinoma develops when normal colon cells acquire genetic mutations that cause uncontrolled growth. While the exact cause is multifactorial, several well‑established risk factors increase susceptibility:

Genetic and Familial Factors

• Family history of colorectal cancer or adenomatous polyps (first‑degree relative diagnosed before age 60).
• Inherited syndromes such as Familial Adenomatous Polyposis (FAP) and Lynch syndrome (hereditary non‑polyposis colorectal cancer).
• Personal history of inflammatory bowel disease (ulcerative colitis or Crohn’s disease).

Lifestyle and Environmental Factors

• Diet high in red or processed meat and low in fiber, fruits, and vegetables.
• Physical inactivity – sedentary lifestyle doubles risk.
• Obesity – Body Mass Index (BMI) ≥30 increases risk by ~30%.
• Alcohol consumption – heavy use (>2 drinks/day) is linked to higher rates.
• Tobacco smoking – current smokers have a 20–30% higher risk.

Other Factors

• Age ≥50 years.
• Type 2 diabetes mellitus.
• Prior radiation therapy to the abdomen or pelvis.

Diagnosis

Because early disease may be asymptomatic, screening is the cornerstone of diagnosis.

Screening Tests

• Colonoscopy – gold standard; allows direct visualization and removal of polyps.
• Flexible sigmoidoscopy – visualizes the distal colon; may be combined with stool testing.
• Stool‑based tests
  • Fecal Immunochemical Test (FIT) – detects hidden blood.
  • Multi‑target stool DNA test (e.g., Cologuard) – detects DNA mutations and blood.
• CT colonography (virtual colonoscopy) – imaging alternative for patients unable to undergo colonoscopy.

Diagnostic Work‑up After a Positive Screening Test

1. Diagnostic colonoscopy with biopsy – tissue is examined histologically to confirm adenocarcinoma.
2. Staging investigations to assess spread:
   • Contrast‑enhanced CT of the abdomen and pelvis.
   • MRI of the pelvis (especially for low rectal cancers).
   • Chest CT to evaluate lung metastases.
   • Positron Emission Tomography (PET)/CT for occult metastases.
3. Laboratory tests – complete blood count (CBC) for anemia, liver function tests, carcinoembryonic antigen (CEA) level for baseline monitoring.

Treatment Options

Treatment is individualized based on tumor stage (TNM classification), location, patient health, and preferences. Multimodal therapy is common.

Surgery

• Localized disease (Stage I‑II) – segmental colectomy (removal of the tumor‑bearing portion of colon) with regional lymph node excision.
• Advanced disease (Stage III) – colectomy plus adjuvant chemotherapy.
• Metastatic disease (Stage IV) – surgery may be curative if metastases are resectable (e.g., liver metastasectomy).

Systemic Therapy

• Adjuvant chemotherapy – typically 5‑fluorouracil (5‑FU) or capecitabine combined with oxaliplatin (FOLFOX or CAPEOX) for 3–6 months.<sup>Mayo Clinic</sup>
• Neoadjuvant (pre‑operative) chemotherapy** – used for borderline resectable tumors.
• Targeted therapies –
  • Anti‑VEGF agents (bevacizumab) for RAS‑wildtype disease.
  • Anti‑EGFR antibodies (cetuximab, panitumumab) for KRAS/NRAS wild‑type tumors.
• Immunotherapy – checkpoint inhibitors (pembrolizumab, nivolumab) for microsatellite instability‑high (MSI‑H) or mismatch repair‑deficient (dMMR) tumors.<sup>CDC</sup>

Radiation Therapy

Rarely used for colon cancer because the colon is mobile, but may be considered for palliation of symptomatic metastases or in cases of locally advanced disease involving adjacent structures.

Supportive & Lifestyle Measures

• Nutrition counseling to maintain weight and manage chemotherapy‑related side effects.
• Physical activity programs to improve stamina and quality of life.
• Psychosocial support – counseling, support groups, and survivorship programs.

Living with Adenocarcinoma (Colon)

Adjusting to a cancer diagnosis involves practical steps that can improve outcomes and daily comfort.

Follow‑Up Care

• Regular clinic visits every 3–6 months for the first 2 years, then annually.
• Serial CEA measurements; rising levels may signal recurrence.
• Periodic colonoscopies – typically at 1 year post‑resection, then every 3–5 years if normal.

Managing Side Effects

• Diarrhea – stay hydrated, use loperamide as directed, limit high‑fat foods.
• Peripheral neuropathy from oxaliplatin – dose adjustments, gabapentin or duloxetine for symptom control.
• Fatigue – schedule rest periods, engage in light exercise, assess for anemia.
• Emotional health – consider therapy, mindfulness, or cancer support groups.

Practical Tips

1. Maintain a food diary to identify triggers for GI symptoms.
2. Take prescribed vitamins (e.g., folic acid) if recommended after surgery.
3. Keep a medication list and share it with every health‑care provider.
4. Use a medical alert bracelet indicating a history of colon cancer, especially if you are on long‑term anticoagulants.

Prevention

While you cannot change genetic predisposition, many modifiable factors lower risk:

• Screen regularly – colonoscopy every 10 years (or FIT yearly) beginning at age 45 for average‑risk adults.<sup>CDC</sup>
• Eat a plant‑rich diet – at least 5 servings of fruits/vegetables daily, whole grains, and legumes.
• Limit red/processed meat to < 18 oz per week.
• Stay active – at least 150 minutes of moderate aerobic activity weekly.
• Maintain healthy weight – BMI 18.5‑24.9.
• Avoid tobacco and excess alcohol – quit smoking; limit alcohol to ≤1 drink/day for women, ≤2 drinks/day for men.
• Consider chemoprevention – low‑dose aspirin (81 mg) may reduce risk for some high‑risk individuals, but discuss with a physician.

Complications

If left untreated or when disease progresses, several serious complications may arise:

• Intestinal obstruction – blockage causing severe abdominal pain, vomiting, and inability to pass gas or stool.
• Perforation – a hole in the colon wall leading to peritonitis, a life‑threatening infection.
• Bleeding – can cause anemia, faintness, and require transfusion.
• Metastatic spread – commonly to liver, lungs, peritoneum, or distant lymph nodes, leading to organ dysfunction.
• Cachexia – severe weight loss and muscle wasting, affecting treatment tolerance.
• Secondary infections – especially during chemotherapy‑induced neutropenia.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:

• Sudden, severe abdominal pain that does not improve.
• Vomiting that contains blood or resembles coffee grounds.
• Bright red or black, tarry stools indicating massive gastrointestinal bleeding.
• Signs of bowel obstruction – inability to pass stool or gas, abdominal swelling, and persistent nausea.
• Fever over 101°F (38.3°C) with chills, especially if you are receiving chemotherapy.
• Rapid heart rate, dizziness, or faintness suggesting severe anemia or shock.

Prompt medical attention can be lifesaving.

---

Sources: Mayo Clinic, CDC, American Cancer Society, National Institutes of Health (NIH), Cleveland Clinic, World Health Organization (WHO), peer‑reviewed oncology journals (e.g., Journal of Clinical Oncology, Gastroenterology).

```